ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other ...
MONTREAL, Quebec City — Researchers investigating the use of an apolipoprotein A-1 (ApoA-1) mimetic in aortic valve stenosis have demonstrated that infusion of this peptide improved aortic valve area ...
A new study published in the journal of Diabetic Medicine revealed that elevated apolipoprotein B (ApoB) levels and a higher ...
NEW ORLEANS, LA — One late-breaking clinical trial presented at the American Heart Association 2016 Scientific Sessions has crushed initial enthusiasm for recombinant apolipoprotein A-1 (apoA-1) ...
Higher ApoB/ApoA1 ratio was linked to cardiovascular complications but did not improve predictive value of current models. Higher apolipoprotein B to A1 (ApoB/ApoA1) ratio is linked to both major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results